drugset / Trial / NCT00663390

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR

NCT00663390

Phase 3 Completed 30 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Delicata Pocket.

Timeline

Start
2007-12
Primary completion
2008-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified Topical

Indications

No indication recorded.